START | Jotup

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease

Retrieved on:

Montag, April 22, 2024

“The KOL roundtable we conducted featured a panel of Alzheimer’s disease expert clinicians and researchers who highlighted the need to find Alzheimer’s disease treatments that are less burdensome for patients and their care partners,” said Lisa Ricciardi, Cognition’s president and CEO .

Key Points:

“The KOL roundtable we conducted featured a panel of Alzheimer’s disease expert clinicians and researchers who highlighted the need to find Alzheimer’s disease treatments that are less burdensome for patients and their care partners,” said Lisa Ricciardi, Cognition’s president and CEO .
The SHINE study enrolled participants in the U.S. and several countries in Europe including The Netherlands.
Dr. Vijverberg reviewed the design of the SHINE study and the results of the preliminary analysis of the first 24 patients who finished six months of treatment.
An archive of the KOL roundtable discussion is available on the News & Events page of the Investors section of the Cognition website or may be accessed directly at the following URL: https://lifescievents.com/event/cognition/ .

Ambassador Thomas Graham, Jr. Appointed As Chairman Emeritus of Lightbridge Corporation

Retrieved on:

Donnerstag, April 18, 2024

President Clinton, Georgetown University, Stanford University, Harvard Law School, Nuclear energy, University, Safety, Annual general meeting, Book, Arms control, Princeton University, Comprehensive Nuclear-Test-Ban Treaty, History, START, American Bar Association, Special, LTBR, Nuclear

RESTON, Va., April 18, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Ambassador Thomas Graham, Jr. will be retiring as Executive Chairman and director of Lightbridge effective as of the upcoming Annual Meeting of Shareholders.

Key Points:

RESTON, Va., April 18, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Ambassador Thomas Graham, Jr. will be retiring as Executive Chairman and director of Lightbridge effective as of the upcoming Annual Meeting of Shareholders.
Ambassador Graham has been appointed Chairman Emeritus.
“I am honored to accept the appointment as Chairman Emeritus of Lightbridge,” said Ambassador Graham.
As he transitions to the role of Chairman Emeritus, we look forward to continuing to benefit from his wisdom and guidance.

Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets

Retrieved on:

Dienstag, April 16, 2024

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced final results from the HD cohort of the Phase 4 START study, demonstrating positive real-world effectiveness, safety, adherence and satisfaction with the 4-week Titration Kit for AUSTEDO.

Key Points:

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced final results from the HD cohort of the Phase 4 START study, demonstrating positive real-world effectiveness, safety, adherence and satisfaction with the 4-week Titration Kit for AUSTEDO.
As a fatal, neurodegenerative disease, HD can cause cognitive deterioration, behavioral and/or psychological problems and uncontrollable body movements known as chorea – a symptom that can have a significant impact on daily activities like eating or talking.3-5 These data are being presented at the 2024 American Academy of Neurology (AAN) Annual Meeting.
“90% of HD patients experience chorea,3,4 so it’s important for patients to have a treatment option that not only helps address symptoms, but helps provide a positive patient experience,” said Eric Hughes, MD, PhD, Executive Vice President of Global R&D and Chief Medical Officer at Teva.
“I’m glad to see this outcome as it gives clinicians more confidence and patients more control.”

The START Center for Cancer Research Takes a Major Step Forward in its Mission to Bring the Hope of Cancer Research to Communities Globally

Retrieved on:

Montag, April 8, 2024

The START Center for Cancer Research, the world's largest global site network of early phase oncology clinical trials, sets its sights on expanding access to breakthrough research to all communities globally.

Key Points:

The START Center for Cancer Research, the world's largest global site network of early phase oncology clinical trials, sets its sights on expanding access to breakthrough research to all communities globally.
Slack, a respected leader in the clinical research industry, brings nearly 20 years of experience to grow START's mission of revolutionizing cancer clinical research.
With a global network spanning eight locations, including START San Antonio, START Midwest, START Mountain Region, START Madrid (FJD and CIOCC), START Barcelona, START Dublin, and START Lisbon, START is at the forefront of advancing cancer research.
Co-founders of The START Center for Cancer Research, Amita Patnaik, MD, FRCPC, and Kyriakos P. Papadopoulos, MD, will continue their pivotal roles as Co-directors of Clinical Research at START San Antonio.

Arieli Capital Launching 2nd Cohort of START Agri-Tech Scale-Up Program With 11 Cutting-Edge Ventures

Retrieved on:

Donnerstag, April 4, 2024

The first cohort of the program included 8 ventures, who've collectively raised a combined $9.5M in investment capital and have made impressive milestones after participating.

Key Points:

The first cohort of the program included 8 ventures, who've collectively raised a combined $9.5M in investment capital and have made impressive milestones after participating.
"Our first cohort showcased just how much value can be created through this program, and we knew from then that we'd return with another group."
We're thrilled to work alongside our Utah partners on this impactful program deepening Arieli's existing Utah activity and investments."
Arieli Capital invites the agri-tech and climate-tech community, as well as the broader high-tech ecosystem to take part at the final expo and pitch event, and follow for more updates here.

Galderma to Showcase Latest Updates From Its Broad, Innovative and Leading Dermatology Portfolio at the 2024 American Academy of Dermatology Annual Meeting

Retrieved on:

Mittwoch, Februar 28, 2024

Galderma, the pure-play dermatology category leader, will be showcasing its latest clinical and educational efforts at the American Academy of Dermatology (AAD) Annual Meeting from March 8-12, 2024, highlighting its broad, innovative and leading dermatology portfolio.

Key Points:

Galderma, the pure-play dermatology category leader, will be showcasing its latest clinical and educational efforts at the American Academy of Dermatology (AAD) Annual Meeting from March 8-12, 2024, highlighting its broad, innovative and leading dermatology portfolio.
“Our vast presence at AAD combines new data, novel educational activities and patient perspectives, demonstrating how we are putting our commitment to addressing the needs of the dermatology community into action.
The event is taking place on Saturday, March 9, in the Pacific Ballroom 21-26, Marriott Marquis San Diego Marina, from 7:00 to 9:00 PM PST.
*All presenters are paid consultants or employees of Galderma.

Arieli Capital Unveils START FashionTech in Milan, Merging Couture with Cutting-Edge Technology

Retrieved on:

Donnerstag, Februar 22, 2024

Head, Innovation, Ministry, AI, Growth, Intel Ignite, Milan Fashion Week, Fashion, Authentication, Medicine, Supply chain management, NFC, Agriculture, Microsoft, START, Partner, Cryptocurrency

Scheduled for March 4th-7th in Milan, Italy, soon after Milan Fashion Week, the program will connect FashionTech startups with prominent brands and investors, offering unique growth prospects in the fashion, retail and design industries.

Key Points:

Scheduled for March 4th-7th in Milan, Italy, soon after Milan Fashion Week, the program will connect FashionTech startups with prominent brands and investors, offering unique growth prospects in the fashion, retail and design industries.
We're highly impressed by the advanced and creative ventures in the Fashion space," says Or Haviv, Partner and head of Innovation at Arieli.
Arieli's global programs have previously aided various Italian startups across industries such as agriculture, medicine, and climate establish strong business foundations, raise capital and enter new markets.
The global sustainable fashion market, valued at $7.8B in 2023, is expected to surpass $33B by 2030 with a remarkable CAGR of nearly 23%.

A New Era in Desert Technology: START AgriTech Program Launched in Utah, USA by Arieli Capital & Utah Tech University

Retrieved on:

Donnerstag, Dezember 21, 2023

Senate, Desert Tech, Partnership, Agriculture, Seed, Student, Utah Tech University, Agricultural technology, Climate change, Health, Innovation, Knowledge, Water, Food, START, Innovation Hub, Growth, Haifa Group, Potash

To address these, Arieli Capital LLC ("Arieli") together with Frontier RNG Agro-climate Innovation Hub, in collaboration with Utah Tech University and Haifa Group, are excited to open registration for the START AgriTech Program, taking place April 15-18, 2024, on the Utah Tech Campus in St George, Utah.

Key Points:

To address these, Arieli Capital LLC ("Arieli") together with Frontier RNG Agro-climate Innovation Hub, in collaboration with Utah Tech University and Haifa Group, are excited to open registration for the START AgriTech Program, taking place April 15-18, 2024, on the Utah Tech Campus in St George, Utah.
Utah Tech and Arieli Capital's partnership is a pivotal opportunity for Desert Tech and AgriTech leaders in Utah, marking a significant stride in innovation and growth.
Utah Tech University President Richard "Biff" Williams, "The partnership between Utah Tech University and Arieli Capital marks an exciting collaboration, driving innovation and commercialization in AgTech and Desert Tech within the state, particularly in southwest Utah.
Arieli actively invests in desert and agriculture technologies alongside its innovation center, Frontier, located in the Israeli Negev desert.

Trading Technologies announces new dedicated business lines to fuel growth across asset classes in 2024

Retrieved on:

Mittwoch, Dezember 13, 2023

AIM, Acquisition, Risk management, Data science, Consultant, START, EVP, Edward Morgan, United States Treasury security, QTS, KRM, Growth, TCA, Cryptocurrency

CHICAGO, Dec. 13, 2023 /PRNewswire/ -- Trading Technologies International, Inc. (TT), a global capital markets technology platform provider, today announced the launch of two new lines of business, TT Compliance and TT Quantitative Trading Solutions (QTS), to further support the company's growth into new asset classes. The two dedicated lines of business build on TT's past offerings in trade surveillance and algorithmic/quantitative trading solutions that were strengthened by TT's acquisitions of Abel Noser Solutions – the industry-leading provider of transaction cost analysis (TCA) for investment managers, brokers, asset owners and consultants – in August 2023 and RCM-X – a technology provider of algorithmic execution strategies and quantitative trading products – in March 2022.

Key Points:

Todd said: "We are calling the new business line QTS to underscore that our team is not just developers building algos.
These professionals are experts in data science and analytics, along with trading and risk management in multiple asset classes, on top of their coding and development skills.
We're excited to further expand into new asset classes and bring our award-winning tools to a broader user base as we continue to grow our multi-asset offering."
The two new business units are part of a reorganization of the firm into six distinct lines of business that will work in concert to support clients' multi-asset needs.

Trading Technologies announces new dedicated business lines to fuel growth across asset classes in 2024

Retrieved on:

Mittwoch, Dezember 13, 2023

AIM, Acquisition, Risk management, Data science, Consultant, START, EVP, Edward Morgan, United States Treasury security, QTS, KRM, Growth, TCA, Cryptocurrency

CHICAGO, Dec. 13, 2023 /PRNewswire/ -- Trading Technologies International, Inc. (TT), a global capital markets technology platform provider, today announced the launch of two new lines of business, TT Compliance and TT Quantitative Trading Solutions (QTS), to further support the company's growth into new asset classes. The two dedicated lines of business build on TT's past offerings in trade surveillance and algorithmic/quantitative trading solutions that were strengthened by TT's acquisitions of Abel Noser Solutions – the industry-leading provider of transaction cost analysis (TCA) for investment managers, brokers, asset owners and consultants – in August 2023 and RCM-X – a technology provider of algorithmic execution strategies and quantitative trading products – in March 2022.

Key Points:

Todd said: "We are calling the new business line QTS to underscore that our team is not just developers building algos.
These professionals are experts in data science and analytics, along with trading and risk management in multiple asset classes, on top of their coding and development skills.
We're excited to further expand into new asset classes and bring our award-winning tools to a broader user base as we continue to grow our multi-asset offering."
The two new business units are part of a reorganization of the firm into six distinct lines of business that will work in concert to support clients' multi-asset needs.